Voyager Therapeutics Inc (VYGR)
7.62
+0.20
(+2.70%)
USD |
NASDAQ |
Apr 26, 16:00
7.62
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Total Liabilities (Quarterly): 114.96M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 114.96M |
| September 30, 2023 | 118.43M |
| June 30, 2023 | 116.51M |
| March 31, 2023 | 119.33M |
| December 31, 2022 | 100.34M |
| September 30, 2022 | 102.66M |
| June 30, 2022 | 128.55M |
| March 31, 2022 | 148.25M |
| December 31, 2021 | 98.80M |
| September 30, 2021 | 97.35M |
| June 30, 2021 | 98.19M |
| March 31, 2021 | 101.51M |
| December 31, 2020 | 107.26M |
| September 30, 2020 | 103.52M |
| June 30, 2020 | 220.57M |
| March 31, 2020 | 242.85M |
| December 31, 2019 | 255.25M |
| September 30, 2019 | 268.06M |
| Date | Value |
|---|---|
| June 30, 2019 | 270.19M |
| March 31, 2019 | 310.66M |
| December 31, 2018 | 130.58M |
| September 30, 2018 | 131.48M |
| June 30, 2018 | 132.69M |
| March 31, 2018 | 136.73M |
| December 31, 2017 | 50.43M |
| September 30, 2017 | 55.71M |
| June 30, 2017 | 53.12M |
| March 31, 2017 | 52.39M |
| December 31, 2016 | 53.64M |
| September 30, 2016 | 52.86M |
| June 30, 2016 | 54.11M |
| March 31, 2016 | 56.38M |
| December 31, 2015 | 60.38M |
| September 30, 2015 | 64.72M |
| June 30, 2015 | 69.05M |
| December 31, 2014 | 10.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
97.35M
Minimum
Sep 2021
270.19M
Maximum
Jun 2019
148.03M
Average
116.51M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Biogen Inc | 11.35B |
| United Therapeutics Corp | 1.182B |
| MEI Pharma Inc | 19.05M |
| Macrogenics Inc | 145.80M |
| Moderna Inc | 4.572B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 351.28M |
| Shareholders Equity (Quarterly) | 236.32M |
| Current Ratio | 4.956 |